J
2633
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, Jacobson Pharma Corporation Ltd has outperformed Hang Seng (Hong Kong), delivering a return of +6% compared to the Hang Seng (Hong Kong)'s +6% growth.
Stocks Performance
2633 vs Hang Seng (Hong Kong)
Performance Gap
2633 vs Hang Seng (Hong Kong)
Performance By Year
2633 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jacobson Pharma Corporation Ltd
Glance View
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. The company employs 1,723 full-time employees The company went IPO on 2016-09-21. The firm runs its business via two segments. Generic Drugs segment develops, manufactures and distributes a host of off-patent medicine for various therapeutic uses. Currently the activities in this regard are primarily carried out in Hong Kong. Proprietary Chinese Medicines segment develops, manufactures and distributes Chinese medicines. Currently the activities in this regard are primarily carried out in Hong Kong.
